ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Session » Vasculitis - Poster III: Rarer Vasculitides

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 2969
10 Year Retrospective Analysis of 276 Cases of Histopathologically Confirmed Leukocytoclastic Vasculitis
9:00AM-11:00AM
Abstract Number: 2973
A Comparison of Caregiving Burden and Impact in Systemic Vasculitis Versus Other Conditions
9:00AM-11:00AM
Abstract Number: 2979
a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehçEt’s Syndrome Informing the Eular Recommendations for the Management of BehçEt’s Syndrome
9:00AM-11:00AM
Abstract Number: 2947
Adalimumab Versus Infliximab in Cystoid Macular Edema of Uveitis Associated to BehçEt Disease. Multicenter Study of 34 Patients
9:00AM-11:00AM
Abstract Number: 2974
An Outcome Survey of 100 Patients with Cerebral Venous Sinus Thrombosis Due to Behcet’s Syndrome Followed up at a Single, Dedicated Center
9:00AM-11:00AM
Abstract Number: 2954
Anti-IL6-R Tocilizumab in Refractory Uveitis Associated with BehçEt’s Disease. Multicenter Study of 11 Patients
9:00AM-11:00AM
Abstract Number: 2961
Antiphospoholipid Antibodies in Adult IgA Vasculitis: Aps/PT Antibodies As a Potential Marker of Renal Involvement?
9:00AM-11:00AM
Abstract Number: 2966
Assessment of Damage in Behcet’s Disease: Do We Need a Specific Damage Index?
9:00AM-11:00AM
Abstract Number: 2959
Baseline Endothelial Dysfunction Might Predict Immunosuppressive Need in Young, Male Behcet’s Patients with Early Disease: A Prospective Follow-up
9:00AM-11:00AM
Abstract Number: 2940
Bechet’s Disease and Sleep Quality in Korean Patients
9:00AM-11:00AM
Abstract Number: 2963
BehçEt’s Disease in Children: Eastern Mediterranean Experience
9:00AM-11:00AM
Abstract Number: 2955
Biologic Therapy in Severe Peripheral Ulcerative Keratitis (PUK). Multicenter Study of 27 Patients
9:00AM-11:00AM
Abstract Number: 2971
Characteristics and Management of IgA Vasculitis (Henoch-Schönlein purpura) in Adults: Data from the 260 Patients Included in the Igavas Survey
9:00AM-11:00AM
Abstract Number: 2950
Cogan Syndrome: Treatment and Outcome from French Nationwide Retrospective Study and Literature Review of 62 Patients
9:00AM-11:00AM
Abstract Number: 2953
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
9:00AM-11:00AM
Abstract Number: 2952
Differentiation Between Neurosarcoidosis and Primary CNS Vasculitis Based on Clinical and Cerebrospinal Fluid Parameters
9:00AM-11:00AM
Abstract Number: 2976
Disease Flares and Persistent Low-Level of Disease: Long-Term Outcome in a Cohort of Patients with BehçEt’s Disease
9:00AM-11:00AM
Abstract Number: 2968
Efficacy of Anti-TNF Alpha in Severe and Refractory Cardiovascular Involvement  of Behcet’s Disease: A Multicenter Observational Study of 18 Patients
9:00AM-11:00AM
Abstract Number: 2962
Expression Profile of Chemokines Is Skewed to Th17/Th22 Recruitment in Circulation of Patients with Behcet’s Disease
9:00AM-11:00AM
Abstract Number: 2948
Fecal Calprotectin Level Is Useful in Identifying Active Disease in Behçet’s Syndrome Patients with Gastrointestinal Involvement: A Controlled Study
9:00AM-11:00AM
Abstract Number: 2958
Hypocomplementemic Urticarial Vasculitis (HUV) Syndrome in Two Geographically Defined Populations of Sweden
9:00AM-11:00AM
Abstract Number: 2967
Identifying Core Domains for BehçEt’s Syndrome Trials: An International Physician and Patient Delphi Exercise
9:00AM-11:00AM
Abstract Number: 2970
Incidence and Characteristics of Vasculitis Associated with Monoclonal Antibodies and Peptide Fusion Proteins: A Survey from the French National Pharmacovigilance Database
9:00AM-11:00AM
Abstract Number: 2975
Increase of Sacroiliitis By Follow-up and Routine CT in Patients with Behcet’s Disease
9:00AM-11:00AM
Abstract Number: 2960
Increased Post-Thrombotic Syndrome Is Unassociated with Anticoagulant Use in Vascular Behcet’s Disease
9:00AM-11:00AM
Abstract Number: 2980
Inflammation As an Under-Recognized Cause of Ascending Aortic Aneurysms: A Single-Center Clinical and Pathological Study of 53 Cases over 6 Years
9:00AM-11:00AM
Abstract Number: 2946
Large Scale Genetic Analysis in BehçEt Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci
9:00AM-11:00AM
Abstract Number: 2965
Late-Onset Relapse in Patients with Systemic Vasculitis
9:00AM-11:00AM
Abstract Number: 2941
Optimization of Adalimumab on Refractory Uveitis of Behcet’s Syndrome. Multicenter Study of 23 Patients
9:00AM-11:00AM
Abstract Number: 2956
Optimization of Thiopurines with a Xanthine Oxidase Inhibitor in Patients with Autoimmune Systemic Diseases
9:00AM-11:00AM
Abstract Number: 2951
Patient Outcomes in Primary Angiitis of the Central Nervous System
9:00AM-11:00AM
Abstract Number: 2957
Primary Central Nervous System Vasculitis Associated with Lymphomas
9:00AM-11:00AM
Abstract Number: 2981
Prospective Cohort of Surgically-Diagnosed Aortitis at the Ottawa Hospital
9:00AM-11:00AM
Abstract Number: 2978
Psychiatric Involvement and Behcet’S Syndrome: Does Bipolar Disorder Represent a Clinical Feature of the Disease?
9:00AM-11:00AM
Abstract Number: 2943
Relationship Between  Menstruation and Symptoms of Behcet’s Syndrome
9:00AM-11:00AM
Abstract Number: 2939
Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis
9:00AM-11:00AM
Abstract Number: 2942
Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease
9:00AM-11:00AM
Abstract Number: 2949
Surgical Method for Aortic Root Involvement of Behcet Disease
9:00AM-11:00AM
Abstract Number: 2945
Systematic Review: “Efficacy and Safety of Biological Versus Immunosuppressive Therapy Compared to Placebo in the Treatment of Uveitis Associated with BehçEt’s Disease.”
9:00AM-11:00AM
Abstract Number: 2964
Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients
9:00AM-11:00AM
Abstract Number: 2977
Treatment of Cryoglobulinemic Vasculitis with Sofosbuvir in Four Combination Protocols
9:00AM-11:00AM
Abstract Number: 2944
Use of Muscle Biopsies for the Diagnosis of Systemic Vasculitis in a Rheumatology Service
9:00AM-11:00AM
Abstract Number: 2972
Vaccination and Risk of Childhood IgA Vasculitis (Henoch–Schönlein): A Case-Crossover Analysis

« View all sessions from this meeting

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology